Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $22,068 purchase order by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The firm fixed price contract is for maintenance services to be performed between January 1, 2024 and December 31, 2024 at the prime contractor's facility in Hopkinton, Massachusetts. No additional details were provided regarding the original solicitation or products/services requested. The award does not appear to be associated with a larger governmentwide acquisition contract vehicle. The NCI and NIH support research aimed at discovering prevention and cures for cancer and other diseases.
Generated 12/28/23, 9:22 AM